NCT00638456 - Use of Topical Budesonide in the Treatment of Eosinophilic Esophagitis | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

February 29, 2008

Primary Completion Date

September 30, 2009

Study Completion Date

September 30, 2009

Conditions

Eosinophilic Esophagitis

Interventions

DRUG

Budesonide plus Prevacid

Budesonide is taken daily for three months. In addition, Prevacid is taken twice daily for three months.

DRUG

placebo plus Prevacid

Placebo is taken daily for three months. In addition, Prevacid is taken twice daily for three months.

Trial Locations (1)

Rady Children's Hospital, San Diego, San Diego